<DOC>
	<DOCNO>NCT00666679</DOCNO>
	<brief_summary>This study assess inhale corticosteroid plus montelukast compare inhaled corticosteroid therapy alone treatment patient chronic asthma .</brief_summary>
	<brief_title>Study Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone Patients With Chronic Asthma ( 0476-386 )</brief_title>
	<detailed_description>During study , patient receive mometasone ( powder , 220 mcg once-daily , approximately 6 week ) . In crossover manner , eligible patient also receive montelukast ( powder , 1 mg once-daily , approximately 2 week ) follow placebo ; receive placebo follow montelukast . The order 2 treatment add mometasone randomize .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient decrease breathe capacity ( take asthma medicine ) improve take fastacting asthma inhaler Within one month first study visit , patient treat fastacting asthma inhaler , may treat corticosteroid inhaler inhaler combine corticosteroid plus bronchodilator Patient hypersensitive inhale betaagonists , corticosteroid , leukotriene antagonist , component Has require oral corticosteroid rescue worsen asthma screening period</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>